A Phase 2 Proof-of-Concept Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand

Trial Profile

A Phase 2 Proof-of-Concept Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs Gevokizumab (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record .
    • 24 Sep 2013 Planned end date changed from 30 Sep 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 07 Aug 2013 Top-line results are expected in October 2013, according to an XOMA media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top